These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 21635259)
21. Synthesis, biological evaluation, and SAR study of novel pyrazole analogues as inhibitors of Mycobacterium tuberculosis: part 2. Synthesis of rigid pyrazolones. Castagnolo D; Manetti F; Radi M; Bechi B; Pagano M; De Logu A; Meleddu R; Saddi M; Botta M Bioorg Med Chem; 2009 Aug; 17(15):5716-21. PubMed ID: 19581099 [TBL] [Abstract][Full Text] [Related]
22. A new antimycobacterial furanolignan from Leucophyllum frutescens. Alanís-Garza B; Salazar-Aranda R; Ramírez-Durón R; Garza-González E; Waksman de Torres N Nat Prod Commun; 2012 May; 7(5):597-8. PubMed ID: 22799084 [TBL] [Abstract][Full Text] [Related]
23. Antiprotozoal, antimycobacterial, and anti-inflammatory evaluation of Cnidoscolus chayamansa (Mc Vaugh) extract and the isolated compounds. Pérez-González MZ; Gutiérrez-Rebolledo GA; Yépez-Mulia L; Rojas-Tomé IS; Luna-Herrera J; Jiménez-Arellanes MA Biomed Pharmacother; 2017 May; 89():89-97. PubMed ID: 28222400 [TBL] [Abstract][Full Text] [Related]
24. L-proline-catalysed facile green protocol for the synthesis and antimycobacterial evaluation of [1,4]-thiazines. Indumathi S; Perumal S; Banerjee D; Yogeeswari P; Sriram D Eur J Med Chem; 2009 Dec; 44(12):4978-84. PubMed ID: 19781824 [TBL] [Abstract][Full Text] [Related]
25. Inhibition of mycobacterial replication by pyrimidines possessing various C-5 functionalities and related 2'-deoxynucleoside analogues using in vitro and in vivo models. Srivastav NC; Rai D; Tse C; Agrawal B; Kunimoto DY; Kumar R J Med Chem; 2010 Aug; 53(16):6180-7. PubMed ID: 20718497 [TBL] [Abstract][Full Text] [Related]
26. In vitro and in vivo activities of a new lead compound I2906 against Mycobacterium tuberculosis. Lu J; Yue J; Wu J; Luo R; Hu Z; Li J; Bai Y; Tang Z; Xian Q; Zhang X; Wang H Pharmacology; 2010; 85(6):365-71. PubMed ID: 20530976 [TBL] [Abstract][Full Text] [Related]
27. [Relation between chemical structure and antimycobacterial activity against atypical strains. XIII. Thiosalicylanilides]. Waisser K; Kubicová L; Gregor J; Budová J; Andrlová A; Drsata J; Odlerová Z Ceska Slov Farm; 1998 Mar; 47(2):84-6. PubMed ID: 9650366 [TBL] [Abstract][Full Text] [Related]
28. Synthesis and antimycobacterial activity of some 2-pyridinecarboxyamidrazone derivatives. Mamolo MG; Vio L; Banfi E; Predominato M; Fabris C; Asaro F Farmaco; 1992; 47(7-8):1055-66. PubMed ID: 1445613 [TBL] [Abstract][Full Text] [Related]
29. Synthesis and in vitro antitubercular activity of some 1-[(4-sub)phenyl]-3-(4-{1-[(pyridine-4-carbonyl)hydrazono]ethyl}phenyl)thiourea. Sriram D; Yogeeswari P; Madhu K Bioorg Med Chem Lett; 2006 Feb; 16(4):876-8. PubMed ID: 16303302 [TBL] [Abstract][Full Text] [Related]
30. Synthesis, biological activity, and SAR of antimycobacterial 2- and 8-substituted 6-(2-furyl)-9-(p-methoxybenzyl)purines. Braendvang M; Gundersen LL Bioorg Med Chem; 2007 Nov; 15(22):7144-65. PubMed ID: 17804243 [TBL] [Abstract][Full Text] [Related]
31. 5-Nitro-2,6-dioxohexahydro-4-pyrimidinecarboxamides: synthesis, in vitro antimycobacterial activity, cytotoxicity, and isocitrate lyase inhibition studies. Sriram D; Yogeeswari P; Senthilkumar P; Naidu G; Bhat P J Enzyme Inhib Med Chem; 2010 Dec; 25(6):765-72. PubMed ID: 20569083 [TBL] [Abstract][Full Text] [Related]
33. Design and synthesis of antituberculars: preparation and evaluation against Mycobacterium tuberculosis of an isoniazid Schiff base. Hearn MJ; Cynamon MH J Antimicrob Chemother; 2004 Feb; 53(2):185-91. PubMed ID: 14688045 [TBL] [Abstract][Full Text] [Related]
34. Antimycobacterial brominated metabolites from two species of marine sponges. de Oliveira MF; de Oliveira JH; Galetti FC; de Souza AO; Silva CL; Hajdu E; Peixinho S; Berlinck RG Planta Med; 2006 Apr; 72(5):437-41. PubMed ID: 16557458 [TBL] [Abstract][Full Text] [Related]
35. Antimycobacterial terpenoids from Juniperus communis L. (Cuppressaceae). Gordien AY; Gray AI; Franzblau SG; Seidel V J Ethnopharmacol; 2009 Dec; 126(3):500-5. PubMed ID: 19755141 [TBL] [Abstract][Full Text] [Related]
36. Aminopyrazolo[1,5-a]pyrimidines as potential inhibitors of Mycobacterium tuberculosis: Structure activity relationships and ADME characterization. Soares de Melo C; Feng TS; van der Westhuyzen R; Gessner RK; Street LJ; Morgans GL; Warner DF; Moosa A; Naran K; Lawrence N; Boshoff HI; Barry CE; Harris CJ; Gordon R; Chibale K Bioorg Med Chem; 2015 Nov; 23(22):7240-50. PubMed ID: 26522089 [TBL] [Abstract][Full Text] [Related]
37. Anti-tubercular agents. Part IV: Synthesis and antimycobacterial evaluation of nitroheterocyclic-based 1,2,4-benzothiadiazines. Kamal A; Ahmed SK; Reddy KS; Khan MN; Shetty RV; Siddhardha B; Murthy US; Khan IA; Kumar M; Sharma S; Ram AB Bioorg Med Chem Lett; 2007 Oct; 17(19):5419-22. PubMed ID: 17692520 [TBL] [Abstract][Full Text] [Related]
38. Antimycobacterial and antioxidant activities of reserpine and its derivatives. Begum S; Naqvi SQ; Ahmed A; Tauseef S; Siddiqui BS Nat Prod Res; 2012; 26(22):2084-8. PubMed ID: 22273392 [TBL] [Abstract][Full Text] [Related]
39. Design, synthesis and antimycobacterial activity of some novel imidazo[1,2-c]pyrimidines. Chhabria MT; Jani MH Eur J Med Chem; 2009 Oct; 44(10):3837-44. PubMed ID: 19423196 [TBL] [Abstract][Full Text] [Related]
40. Synthesis, biological evaluation and SAR study of novel pyrazole analogues as inhibitors of Mycobacterium tuberculosis. Castagnolo D; De Logu A; Radi M; Bechi B; Manetti F; Magnani M; Supino S; Meleddu R; Chisu L; Botta M Bioorg Med Chem; 2008 Sep; 16(18):8587-91. PubMed ID: 18752962 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]